ReviewCombinatorial chemistry & high throughput screening2026
Role of Cellular Mechanisms in Dengue Pathogenesis: Focus on Immune Cells Interactions.
Review in Combinatorial chemistry & high throughput screening, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Role of Natural Killer (NK) Cells in Dengue Virus Infection: A Narrative Review.Health science reports · 2026Article
- Optimizing the dengue virus infection mouse model: Comparing different backgrounds and infection route for enhanced stability.Animal models and experimental medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dengue is an arbovirus mosquito-borne disease that occurs after an infection with dengue virus. Dengue virus releases E-proteins, which act as binding proteins and enter the host cell after infection. It triggers several cellular reactions and activates the immune system; however, the mechanisms are still poorly understood. Our goal is to find out how these cellular interactions participate in the activation of immune cells and participate in dengue pathogenesis. Once dengue infects the host cell, it follows these steps: (1) dengue virus releases M- protein into the skin of the host, and it infects the Langerhans cells of the skin, which is a dendritic cell and acts as antigen representing cells. (2) After infection with dendritic cells, the virus enters into the blood cells white blood cells (monocytes, lymphocytes, neutrophils, eosinophils, basophils, and macrophages), red blood cells (erythrocytes), and platelets. After blood cell infection, it targets monocytes or macrophage cells and starts replication. Once replication is done, it circulates in all parts of the organ as well as its cells like endothelium (Endotheliocytes), liver (Hepatocytes, Kupffer), tissue macrophages, Bone marrow (Stromal cells) and enhances endothelial permeability possibly by overproducing matrix metalloproteinases (MMPs) and other cellular mediators. (3) Once all monocytes cell of blood gets infected, it activates NK cell, IFN- γ and TNF-α response. (4) MDA5 (melanoma differentiation-associated protein 5) MDA5 protein can function as a cytosolic sensor that recognizes viral double-strand RNA and then triggers the transcription of genes encoding type I interferon (IFN) and RIG-I (retinoic acidinducible gene-I) is an intracellular molecule that responds to viral nucleic acids and activates downstream signalling. Non-structural part of the virus secretes NS protein, which disrupts the endothelial glycocalyx layer (EGL) by enkindling the upregulation of 3 of the 4 endothelial sialidases (cytosolic (Neu 2), plasma membrane (Neu 3), and lysosomal (Neu 1). These sialidases disrupts the endothelial layer, and as an end result, it increases the pathogenesis of dengue fever. Collectively, the various molecules of the dengue virus activate different cellular components of immune cells, leading to immune dysfunctions and causing severe dengue pathogenesis.
Indexed as
Identifiers
39936442What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.